ArticleAmerican journal of preventive cardiology2026
Trends in cardiovascular mortality among disaggregated Asian American subgroups: 2018-2022.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asian Americans, one of the fastest-growing racial groups, experienced an increase in cardiovascular disease (CVD) mortality during the COVID-19 pandemic. The objective of our study was to examine specific trends in CVD mortality rates in Asian American subgroups from 2018 through 2022 to better contextualize trends before and after the pandemic. Methods: We analyzed US death certificate data for ischemic heart disease (IHD) and heart failure (HF) in non-Hispanic Asian American subgroups (Chinese, Filipino, Asian Indian, Japanese, Korean, and Vietnamese) and Non-Hispanic White individuals before and during the pandemic. We calculated age-standardized mortality rates, proportional mortality ratios, and annual percent change of age-standardized mortality rates for IHD and HF. Results: During the study period, there was no significant change in IHD mortality rate for all Asian American subgroups and for Non-Hispanic Whites during the study period. HF mortality rate significantly increased in Vietnamese American females (11.6% per year [95% CI, 2.2-23.0]). The highest mortality rates were found in Asian Indian and Filipino American males and Asian Indian American females. Conclusions: There was heterogeneity in cardiovascular mortality rates among Asian American subgroups, with IHD mortality rate stagnant in all subgroups between 2018 to 2022 and HF mortality rate increasing among Vietnamese American females during the study period. Greater surveillance of the burden of and mortality from CVD is needed for all Asian American subgroups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.